1833
McKesson is founded by John McKesson and Charles Olcott to import and sell therapeutic drugs and herbal products
McKesson is founded by John McKesson and Charles Olcott to import and sell therapeutic drugs and herbal products.
HealthcarePaper Trail research
McKesson
A pharmaceutical distributor and healthcare services company that supplies medications and medical products nationwide.
At a Glance
Highlights from available records. Missing information does not mean an activity did not occur.
Tracked federal obligations
$12.3B
2025-09-20–2026-09-19. Commitments to spend, not cash paid.
Inspect records →Largest tracked awarding agency
Department of Veterans Affairs
2025-09-20–2026-09-19 · $12B · 97.5% of tracked obligations
Inspect records →Outside lobbying-firm income
$320K
2026 YTD · latest filings; in-house expenses and outside-firm income are not combined.
Inspect records →Documented people connections
32
Distinct people with published, verified positions in the records shown below.
Inspect records →Industry
Healthcare
Organization classification recorded by Paper Trail.
Inspect records →Federal spending
Total federal obligations
$12.3B
Obligations recorded from September 20, 2025 through September 19, 2026. Obligations are promises by the federal government to spend money, not necessarily cash already paid.
As of
September 19, 2026
Paper Trail overview
About This Organization
A pharmaceutical distributor and healthcare services company that supplies medications and medical products nationwide.
Documented timeline
Company History & Government Roots
Trace how this company developed and how its relationship with government, public funding, federal research, contracts, acquisitions, and political institutions evolved over time.
Editorial context
Why It Is Included
Included because this organization appears in federal spending records and is part of The Paper Trail Project's public-interest research directory.
Paper Trail research
Why you may have heard of it
One of the largest drug distributors in the United States.
Direct public money received
Public Money Profile
Federal obligations are shown by award type and kept separate from tax incentives or workforce public-benefit research. These categories should not be added into a generic “subsidy” figure.
Federal contracts
$12.3BFederal grants
$0Direct payments
$0Federal loans
$0Other assistance
$0No published source-backed estimate linked unless shown elsewhere on this profile.
Not included without attributable official records.
Connection explorer
Follow the Full Trail
Move from this organization to federal agencies, spending categories, reviewed corporate relationships, lobbying disclosures, its affiliated PAC, and political recipients.
Open Connection Explorer →Sourced institutional roles
Leadership & People
Lobbying Connections
TAYLOR SEXTON
Registered lobbyist
View sourced career record →BEN LEE MCMAKINRegistered lobbyist
View sourced career record →ERIC BERGRENRegistered lobbyist
View sourced career record →STEVEN R PHILLIPSRegistered lobbyist
View sourced career record →DARREN WILLCOXRegistered lobbyist
View sourced career record →JEFF LUCASRegistered lobbyist
View sourced career record →JULIE HERSHEY CARRRegistered lobbyist
View sourced career record →KATHERINE FLEMING COTTONRegistered lobbyist
View sourced career record →JORDAN SMITHRegistered lobbyist
View sourced career record →NANCY MACAN MCNALLYRegistered lobbyist
View sourced career record →JOEL WHITERegistered lobbyist
View sourced career record →JENNIFER STEGERRegistered lobbyist
View sourced career record →LORI DENHAMRegistered lobbyist
View sourced career record →MARY DEE BEALRegistered lobbyist
View sourced career record →NICHOLAS UEHLECKERegistered lobbyist
View sourced career record →CHARLES DENTRegistered lobbyist
View sourced career record →LOUIS AGNELLORegistered lobbyist
View sourced career record →JOEL WHITERegistered lobbyist
View sourced career record →DANIEL M TODDRegistered lobbyist
View sourced career record →SLOANE SALZBURGRegistered lobbyist
View sourced career record →JESSICA WOOLLEYRegistered lobbyist
View sourced career record →SEAN D'ARCYRegistered lobbyist
View sourced career record →TED LEHMANRegistered lobbyist
View sourced career record →VIRGIL MILLERRegistered lobbyist
View sourced career record →CHRISTOPHER ARMSTRONG TREANORRegistered lobbyist
View sourced career record →PAUL EDATTELRegistered lobbyist
View sourced career record →ANDREW KENTRegistered lobbyist
View sourced career record →NICOLAS MAGALLANESRegistered lobbyist
View sourced career record →KIMBERLY LINTHICUMRegistered lobbyist
View sourced career record →JOSE BORJONRegistered lobbyist
View sourced career record →JENNIFER STEGERRegistered lobbyist
View sourced career record →LESLIE ZELENKORegistered lobbyist
View sourced career record →Federal data
Spending Over Time
Prime-award transaction obligations attributed to this USAspending recipient. Negative totals can reflect deobligations or corrections.
$8.8BFY2017
$9BFY2018
$9.7BFY2019
$10.1BFY2020
$12.6BFY2021
$12.3BFY2022
$10.2BFY2023
$9BFY2024
$11.9BFY2025
$12.3BFY2026To date
The current fiscal year is partial and will change as USAspending publishes additional transactions.
Federal data
Who funds McKesson?
The federal agencies and offices responsible for the organization’s recorded obligations.
1Department of Veterans Affairs$12,001,632,61597.5% of total2Department of Justice$194,122,6891.6% of total3Department of Health and Human Services$93,415,1700.8% of total4Department of Homeland Security$21,756,4000.2% of total5Peace Corps$468,2070.0% of total6Department of State$00.0% of total
ConnectedLast refreshed September 19, 2026
Prime-award transaction obligations from 2025-09-20 through 2026-09-19, grouped by top-tier awarding agency.
Federal data
What Federal Agencies Bought or Funded From McKesson
USAspending classifies federal obligations using product and service codes for contracts and assistance-listing categories for grants and other assistance. These records describe federal awards to the organization—not the organization’s own operating expenses.
Products and services
DRUGS AND BIOLOGICALS
PSC 6505
$12,302,649,41499.9% of total
CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY
PSC 3650
$5,020,0800.0% of total
PHARMACY SERVICES
PSC Q517
$2,010,3620.0% of total
MEDICAL- MANAGED HEALTHCARE
PSC Q201
$949,5220.0% of total
MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
PSC 6515
$532,6570.0% of total
FOOD, OILS AND FATS
PSC 8945
$205,9350.0% of total
BLOOD AND BLOOD PRODUCTS
PSC 6506
$14,6220.0% of total
LABORATORY EQUIPMENT AND SUPPLIES
PSC 6640
$7,8350.0% of total
MEDICAL- OTHER
PSC Q999
$4,6540.0% of total
REPLENISHABLE FIELD MEDICAL SETS, KITS, AND OUTFITS
PSC 6545
$00.0% of total
Prime-award transaction obligations from 2025-09-20 through 2026-09-19. Categories can be broad and reflect federal coding, not Paper Trail editorial conclusions. View USAspending source ↗
Corporate structure
What does McKesson control?
Business segments, subsidiaries, joint ventures, and acquired companies connected to the parent organization.
Legal-subsidiary lists are drawn from reviewed SEC Exhibit 21 filings. Companies may omit subsidiaries that are not considered significant under SEC reporting rules, so these lists are not necessarily exhaustive.
Legal subsidiaries13
McKesson Europe Services GmbH
Germany
SEC filing source ↗McKesson International IP2A Limited
Malta
SEC filing source ↗McKesson International IP5A Limited
Malta
SEC filing source ↗McKesson Medical-Surgical Holdings, Inc
United States
SEC filing source ↗McKesson Medical-Surgical Minnesota Supply Inc
United States
SEC filing source ↗McKesson Medical-Surgical Supply Chain Services LLC
United States
SEC filing source ↗McKesson Medical-Surgical Top Holdings, Inc
United States
SEC filing source ↗McKesson Plasma and Biologics LLC
United States
SEC filing source ↗McKesson Sourcing Services Inc
United States
SEC filing source ↗McKesson Specialty Care Distribution LLC
United States
SEC filing source ↗McKesson UK Finance I Limited
United Kingdom
SEC filing source ↗McKesson US Finance Corporation
United States
SEC filing source ↗Northstar International Holdings Limited
Malta
SEC filing source ↗Federal disclosures
Federal Lobbying
In-house lobbying expenses · 2026 YTD
$0
Expenses reported on filings where the organization registers and lobbies on its own behalf.
Outside lobbying-firm income · 2026 YTD
$320K
Income reported by outside registrants for work on behalf of this client.
These categories are shown separately and are not added together. An organization’s expense estimate may already include payments to outside firms, depending on its reporting method.
Lobbying over time
| Year | In-house expenses | Outside-firm income |
|---|---|---|
| 2015 | $0 | $420K |
| 2016 | $0 | $330K |
| 2017 | $0 | $360K |
| 2018 | $0 | $360K |
| 2019 | $0 | $500K |
| 2020 | $0 | $380K |
| 2021 | $0 | $430K |
| 2022 | $0 | $470K |
| 2023 | $0 | $380K |
| 2024 | $0 | $510K |
| 2025 | $0 | $570K |
| 2026 | $0 | $320K |
What they lobbied on
Medicare/Medicaid · 68Health Issues · 54Pharmacy · 28Taxation/Internal Revenue Code · 10Veterans · 9Copyright/Patent/Trademark · 1
Outside lobbying firms
| Firm / registrant | Active filings | Reported income |
|---|---|---|
| TODD STRATEGY GROUP | 46 | $2.3M |
| HORIZON GOVERNMENT AFFAIRS | 14 | $620K |
| W STRATEGIES, LLC | 14 | $500K |
| AKIN GUMP STRAUSS HAUER & FELD | 14 | $680K |
| VAN NESS FELDMAN, LLP | 8 | $320K |
| KOUNTOUPES DENHAM CARR & REID, LLC | 6 | $340K |
| DLA PIPER LLP (US) | 3 | $170K |
| MONUMENT ADVOCACY | 2 | $100K |
Only the latest filing in each registrant/client/quarter series contributes to these totals.
Lobbyists listed on disclosures
ANDREW KENT
BEN LEE MCMAKIN
CHARLES DENT
Covered position: Member of Congress
CHRISTOPHER ARMSTRONG TREANOR
DANIEL M TODD
Covered position: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
DARREN WILLCOX
Covered position: Asst. for Policy, Speaker Dennis Hastert; Admin. Asst., Legislative Director, Legislative Asst., Cong. Porter Goss; House Rules Comm. Assoc., Subcommittee Staff Director
ERIC BERGREN
Covered position: Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker
JEFF LUCAS
Covered position: Health Policy Advisor, Senator Bill Cassidy; Legislative Assistant/Sr. Legislative Assistant/Legislative Correspondent, Representative Larry Bucshon
JENNIFER STEGER
Covered position: Scheduler/Legislative Assistant, Rep. Jean Schmidt; Executive Assistant/Legislative Assistant, Rep. Jim Gerlach
JENNIFER STEGER
JESSICA WOOLLEY
Covered position: Legislative Assistant to Reps. Bean, Schuler, Loebsack, Hill and Obey
JOEL WHITE
JOEL WHITE
Covered position: Former Staff Director, House Ways & Means Health Subcommittee; L.A. for Rep. Chris Shays
JORDAN SMITH
JOSE BORJON
Covered position: CoS, Rep V.Gonzalez, Jan 17- Feb 21; Snr Advsr/Dpty CoS, Rep F.Vela, Jun 14- Jan 17; Comm Drctr, Rep Gallego, Dec 13- Jan 15; Drctr Strtgy/Comm, Rep Reyes, Nov 11- Jan 13; Press Sec, Rep Cuellar, Jan 11- Nov 11; Comm Drctr, Rep Ortiz, Mar 09- Jan 11
JULIE HERSHEY CARR
KATHERINE FLEMING COTTON
Covered position: Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie
KIMBERLY LINTHICUM
Covered position: Legislative Director, Representative Bob Franks; Legislative Correspondent, Representative Charles Taylor; Legislative Correspondent, Representative Bill Martini
LESLIE ZELENKO
LORI DENHAM
LOUIS AGNELLO
Covered position: Snr Cnsl, Joint Econ Committee, Mar 17-Nov 17; Leg cnsl, Sen Heinrich, Apr 14-Mar 17; Leg Asst, Rep Doris Matsui, Dec 11-Apr 14; Leg Asst, Senate Judiciary Committee, May 09-Aug 09; Research Analyst, Senate Small Business Committee, Jun 07-Aug 08
MARY DEE BEAL
NANCY MACAN MCNALLY
NICHOLAS UEHLECKE
Covered position: Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee
NICOLAS MAGALLANES
Covered position: Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
PAUL EDATTEL
Covered position: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg
SEAN D'ARCY
SLOANE SALZBURG
Covered position: Health Policy Fellowship, Rep. Phil Gingrey
STEVEN R PHILLIPS
TAYLOR SEXTON
Covered position: Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess
TED LEHMAN
Covered position: Chief of Staff, Senator Tillis; Senate Judiciary Committee-Counsel, then Chief Counsel for Nominations and Senior Counsel; Senate Judiciary Committee-Staff Assistant and Legislative Assistant
VIRGIL MILLER
Filing-level audit trail
Superseded filings remain visible for auditability but are excluded from every total above.
2nd Quarter (Apr 1 - June 30) 2026 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- b1cec471-7504-4d39-ad66-3c34cd066e8b
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 21, 2026
Medicare/Medicaid
General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
2nd Quarter (Apr 1 - June 30) 2026 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
- Filing ID
- 07797f6b-eb0d-4f96-86d7-eb4a9f841452
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2026
Health Issues
Issues related to the pharmaceutical supply chain and drug shortages. Issues related to independent physician practices and community-based care.
Pharmacy
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
2nd Quarter (Apr 1 - June 30) 2026 · MONUMENT ADVOCACY · $50K · Active
- Filing ID
- edaed3c9-a0aa-45b5-aa14-6fe3f1ff9b6c
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- MONUMENT ADVOCACY
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2026
Health Issues
ECAPS and Main Street Pharmacy Act; AI for clinical care; Protecting Patient Access to Cancer and Complex Therapies Act (Murphy)
1st Quarter (Jan 1 - Mar 31) 2026 · MONUMENT ADVOCACY · $50K · Active
- Filing ID
- 93bb5d49-53a4-4690-abf0-8f2912e1eb23
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- MONUMENT ADVOCACY
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2026
Health Issues
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency, 2026 rule and drug reimbursement changes.
1st Quarter (Jan 1 - Mar 31) 2026 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 60d39ab9-6857-412d-a13b-14475d530211
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2026
Medicare/Medicaid
General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
1st Quarter (Jan 1 - Mar 31) 2026 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
- Filing ID
- 72f20216-017c-481e-a946-7f1e11e691c9
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 15, 2026
Health Issues
Issues related to the pharmaceutical supply chain and drug shortages.
Pharmacy
Issues related to H.R. 3164, Ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act. Issues related to pharmacies and patient access.
4th Quarter (Oct 1 - Dec 31) 2025 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- b0c6112f-06f5-4900-8522-9a9ce0014035
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 21, 2026
Medicare/Medicaid
General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
4th Quarter (Oct 1 - Dec 31) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
- Filing ID
- 25e60ea0-90f2-4ea7-9713-6c22c34687d1
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 16, 2026
Health Issues
Issues related to the pharmaceutical supply chain and drug shortages.
Pharmacy
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
3rd Quarter (July 1 - Sep 30) 2025 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 9fda04e3-829f-48e8-a28e-c956d063fed8
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2025
Medicare/Medicaid
General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
3rd Quarter (July 1 - Sep 30) 2025 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- 0135ce57-6d67-4512-b2d2-67ef3ca1b9ec
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 14, 2025
Health Issues
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency.
3rd Quarter (July 1 - Sep 30) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
- Filing ID
- 911a576e-496f-47e7-a14b-0b5ff8339952
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 14, 2025
Health Issues
Issues related to the pharmaceutical supply chain and drug shortages.
Pharmacy
Issues related to H.R. 3164, ensuring Community Access to Pharmacist Services Act. and S.2426, Equitable Community Access to Pharmacist Services Act.
2nd Quarter (Apr 1 - June 30) 2025 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 87606b72-d6c2-4132-8f57-70486b89b67d
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2025
Medicare/Medicaid
General Medicare/Medicaid Issues. Transparency Requirements. Emergency Preparedness.
2nd Quarter (Apr 1 - June 30) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $60K · Active
- Filing ID
- e8283aad-0d95-463d-acae-4c8d7ae6cd5e
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 17, 2025
Health Issues
Issues related to the pharmaceutical supply chain and drug shortages.
2nd Quarter (Apr 1 - June 30) 2025 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- a8fa5079-732f-4f15-a4fd-3fa6d974bcb3
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 11, 2025
Health Issues
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency and PBM reform legislation.
1st Quarter (Jan 1 - Mar 31) 2025 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 9ba287b6-1f8b-425a-964c-0fd7f44d264e
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 21, 2025
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.
1st Quarter (Jan 1 - Mar 31) 2025 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- 0b9777ac-59b0-4116-b09f-8a5895a16f98
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 16, 2025
Health Issues
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency and PBM reform legislation.
1st Quarter (Jan 1 - Mar 31) 2025 · KOUNTOUPES DENHAM CARR & REID, LLC · $40K · Active
- Filing ID
- 7a40a659-7ac4-4534-bd92-b42e035368cf
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- KOUNTOUPES DENHAM CARR & REID, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 15, 2025
Health Issues
Issues related to the pharmaceutical supply chain and drug shortages.
4th Quarter (Oct 1 - Dec 31) 2024 · W STRATEGIES, LLC · $30K · Active
- Filing ID
- 3c4f14a6-9208-49b8-be51-8d1f5efafa12
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- W STRATEGIES, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 21, 2025
Pharmacy
Issues related to the drug supply chain, transparency and patient access to medicines.
Medicare/Medicaid
H.R.1770 - Equitable Community Access to Pharmacist Services Act.
4th Quarter (Oct 1 - Dec 31) 2024 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- 67b95817-2fe6-4bfb-b9a8-22f12d8abcdd
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 19, 2025
Health Issues
Issues around interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency including HR5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages, HR 3561, the PATIENT Act relating to transparency and reporting requirements, and HR 7623, the Telehealth Modernization Act of 2024 and HR 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act relating to transparency and reporting requirements.
4th Quarter (Oct 1 - Dec 31) 2024 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- c6e910f8-0bab-407f-bdd7-2c58146ad603
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 15, 2025
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug Shortages.
3rd Quarter (July 1 - Sep 30) 2024 · W STRATEGIES, LLC · $30K · Active
- Filing ID
- 4f4dae52-115d-4202-9782-a9c684aec015
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- W STRATEGIES, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2024
Pharmacy
Issues related to the drug supply chain, transparency and patient access to medicines.
Medicare/Medicaid
H.R.1770 - Equitable Community Access to Pharmacist Services Act.
3rd Quarter (July 1 - Sep 30) 2024 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 05c24cba-07e7-400d-a013-1ce749c1b397
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2024
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug shortages.
3rd Quarter (July 1 - Sep 30) 2024 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- f6ccd23a-335f-4cc8-8aa9-3f7d2c1d0d9f
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 17, 2024
Health Issues
Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency including HR5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages, HR 3561, the PATIENT Act relating to transparency and reporting requirements, and HR 7623, the Telehealth Modernization Act of 2024 and HR 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act relating to transparency and reporting requirements.
2nd Quarter (Apr 1 - June 30) 2024 · W STRATEGIES, LLC · $30K · Active
- Filing ID
- d25888e8-75e0-49ea-a285-908b2a1af0a1
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- W STRATEGIES, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 22, 2024
Pharmacy
Issues related to the drug supply chain, transparency and patient access to medicines.
2nd Quarter (Apr 1 - June 30) 2024 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 0f7358b5-2606-45f9-89cc-219b037af53d
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 19, 2024
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness. Drug shortages.
2nd Quarter (Apr 1 - June 30) 2024 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- 27f28ae9-f5eb-4382-bb6c-afe580753672
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 15, 2024
Health Issues
Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency including HR5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages, HR 3561, the PATIENT Act relating to transparency and reporting requirements, and HR 7623, the Telehealth Modernization Act of 2024 and HR 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act relating to transparency and reporting requirements.
1st Quarter (Jan 1 - Mar 31) 2024 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 6ea81c52-d627-4572-b0cf-65f192858dd1
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 23, 2024
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.
1st Quarter (Jan 1 - Mar 31) 2024 · W STRATEGIES, LLC · $20K · Active
- Filing ID
- a2564afc-f007-4883-9bfc-b9b422fe8cd0
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- W STRATEGIES, LLC
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 22, 2024
Pharmacy
Issues related to the drug supply chain, transparency and patient access to medicines.
1st Quarter (Jan 1 - Mar 31) 2024 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- f08a6801-f6c6-457c-aedd-e7ef9dfeb299
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 14, 2024
Health Issues
Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, drug shortages and healthcare transparency including HR5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages and the Patient Transparency bill (the Patient Act in house, the help and finance bills).
4th Quarter (Oct 1 - Dec 31) 2023 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 529f22ab-f787-4c71-b59a-ea9a629898c1
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 23, 2024
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.
4th Quarter (Oct 1 - Dec 31) 2023 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- 93e30730-e47e-4020-81ad-559bb5142acc
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 17, 2024
Health Issues
Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, and healthcare transparency including HR 5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages and the Patient Transparency bill (the Patient Act in house, the help and finance bills).
3rd Quarter (July 1 - Sep 30) 2023 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 7a8674aa-d170-479f-a005-8aecf8dd7bf7
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2023
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Emergency Preparedness.
3rd Quarter (July 1 - Sep 30) 2023 · HORIZON GOVERNMENT AFFAIRS · $50K · Active
- Filing ID
- 2a3b76ce-98f3-4dde-aace-3ac54cec6937
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 13, 2023
Health Issues
Issues around the use of real-time benefit tools, interoperability, data privacy and sharing in healthcare, and healthcare transparency including HR 5378, the Lower Costs, More Transparency Act relating to increased price transparency and reporting requirements, drug pricing and shortages and add the PBM reform bill (the Patient Act in house, the help and finance bills).
2nd Quarter (Apr 1 - June 30) 2023 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 483ccf10-b459-470e-aee4-2c339bfd5cbc
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2023
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
2nd Quarter (Apr 1 - June 30) 2023 · HORIZON GOVERNMENT AFFAIRS · $40K · Active
- Filing ID
- 6f206a12-672a-467e-9203-3cc8c60e94cd
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 17, 2023
Health Issues
Electronic Prior Authorizations, issues around the use of real-time benefit tools, healthcare price transparency, interoperability, data privacy and sharing in healthcare, issues around public health reauthorization
1st Quarter (Jan 1 - Mar 31) 2023 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 4d45608c-2070-4c84-b1d0-f9bfea5d1c27
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2023
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
1st Quarter (Jan 1 - Mar 31) 2023 · HORIZON GOVERNMENT AFFAIRS · $40K · Active
- Filing ID
- 477a9063-3ee3-480c-9933-3b4ea7929c4d
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 16, 2023
Health Issues
Electronic Prior Authorizations, issues around the use of real-time benefit tools, healthcare price transparency, interoperability, data privacy and sharing in healthcare
4th Quarter (Oct 1 - Dec 31) 2022 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- e6593da1-e1a3-458c-b077-3dafa63fa33a
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 20, 2023
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
4th Quarter (Oct 1 - Dec 31) 2022 · HORIZON GOVERNMENT AFFAIRS · $40K · Active
- Filing ID
- 50568c89-b06f-4304-905b-ed3b4414b70a
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 18, 2023
Health Issues
Electronic Prior Authorizations, issues around the use of real-time benefit tools, healthcare price transparency, interoperability, data privacy and sharing in healthcare
3rd Quarter (July 1 - Sep 30) 2022 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- e8860974-3494-48c6-af48-510015bb358b
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 21, 2022
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
3rd Quarter (July 1 - Sep 30) 2022 · AKIN GUMP STRAUSS HAUER & FELD · $60K · Active
- Filing ID
- 8c604159-cec8-4e60-9553-96c0d4dceb01
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 20, 2022
Health Issues
Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 7667, Food & Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act.
Pharmacy
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act.
3rd Quarter (July 1 - Sep 30) 2022 · HORIZON GOVERNMENT AFFAIRS · $40K · Active
- Filing ID
- 583b7bc9-8b4e-40e4-bc93-62ab57a36bbf
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 16, 2022
Health Issues
Electronic Prior Authorizations, issues around the use of real-time benefit tools, healthcare price transparency, interoperability, data privacy and sharing in healthcare
2nd Quarter (Apr 1 - June 30) 2022 · AKIN GUMP STRAUSS HAUER & FELD · $60K · Active
- Filing ID
- f58e7697-4782-4465-8873-04f7f11ee524
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2022
Health Issues
Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act; H.R. 7667, Food & Drug Amendments of 2022; S. 4348, the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act
Pharmacy
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act.
2nd Quarter (Apr 1 - June 30) 2022 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 72fbd944-772e-4e76-adad-4e71af4839a4
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2022
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
2nd Quarter (Apr 1 - June 30) 2022 · HORIZON GOVERNMENT AFFAIRS · $10K · Active
- Filing ID
- cb1044bc-a18b-4476-98ba-e00006d47fd0
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- HORIZON GOVERNMENT AFFAIRS
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 19, 2022
Health Issues
Electronic Prior Authorizations, issues around the use of real-time benefit tools, healthcare price transparency, interoperability, data privacy and sharing in healthcare, implementation of HR 133, the Consolidated Appropriations Act 2021
1st Quarter (Jan 1 - Mar 31) 2022 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 732a343a-a87e-4023-b07c-f4a36a831ebf
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2022
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
1st Quarter (Jan 1 - Mar 31) 2022 · AKIN GUMP STRAUSS HAUER & FELD · $60K · Active
- Filing ID
- f137bd02-22e7-4bf7-be5a-ebd9c39477d6
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 19, 2022
Health Issues
Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act
4th Quarter (Oct 1 - Dec 31) 2021 · AKIN GUMP STRAUSS HAUER & FELD · $60K · Active
- Filing ID
- b2406ffe-fcca-4824-be9f-4796290fa966
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 20, 2022
Health Issues
Issues related to COVID medical response,; COVID-19 vaccine distribution,; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act
Medicare/Medicaid
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution.
4th Quarter (Oct 1 - Dec 31) 2021 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 392d9e46-2e4a-417e-9011-7eb4de24a2b7
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 20, 2022
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. Strategic National Stockpile. COVID-19 Response.
3rd Quarter (July 1 - Sep 30) 2021 · AKIN GUMP STRAUSS HAUER & FELD · $60K · Active
- Filing ID
- 2af7156e-929e-4b98-b632-9c65f237dc7e
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 20, 2021
Health Issues
Issues related to COVID medical response; COVID-19 vaccine distribution; and health disparities; S.1362 - Pharmacy and Medically Underserved Areas Enhancement Act.
Medicare/Medicaid
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 - Heroes Act, and COVID-19 vaccine distribution.
3rd Quarter (July 1 - Sep 30) 2021 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 121f9900-0a0f-40b6-bd07-6e7c0628f6f7
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 15, 2021
Medicare/Medicaid
General Medicare/Medicaid Issues. Prescription Drug Price Reform. Transparency Requirements. COVID-19 Response.
2nd Quarter (Apr 1 - June 30) 2021 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 5648e139-bd56-4a73-84ae-528d82877e02
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Aug 16, 2021
Medicare/Medicaid
General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform. COVID-19 Response.
2nd Quarter (Apr 1 - June 30) 2021 · TODD STRATEGY GROUP · $50K · Superseded
- Filing ID
- 01e6bfa3-9c60-4fb4-9b7c-1ffb323a606f
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 21, 2021
- Superseded by
- 5648e139-bd56-4a73-84ae-528d82877e02
Medicare/Medicaid
General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform. COVID-19 Response.
2nd Quarter (Apr 1 - June 30) 2021 · AKIN GUMP STRAUSS HAUER & FELD · $60K · Active
- Filing ID
- 11216618-cb20-4e48-b8d3-8b2c1e4256e3
- Filing type
- 2nd Quarter - Report (Q2)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jul 20, 2021
Health Issues
Issues related to COVID medical response; COVID-19 vaccine distribution; and health disparities
Medicare/Medicaid
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution.
1st Quarter (Jan 1 - Mar 31) 2021 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 3cb65865-c63d-4704-a231-01c24c439c21
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2021
Medicare/Medicaid
General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform. COVID-19 Response.
1st Quarter (Jan 1 - Mar 31) 2021 · AKIN GUMP STRAUSS HAUER & FELD · $50K · Active
- Filing ID
- 4b4ede44-d199-4cbb-9c60-208e2d4c407d
- Filing type
- 1st Quarter - Report (Q1)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Apr 20, 2021
Health Issues
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, H.R. 133 Coronavirus Response and Relief Act, health disparities, and COVID-19 vaccine distribution.
Medicare/Medicaid
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution
4th Quarter (Oct 1 - Dec 31) 2020 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 2e8126ca-1b5e-4ed7-a700-cf5b0f3bdf94
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 21, 2021
Medicare/Medicaid
General Medicare/Medicaid Issues. Centers for Medicare and Medicaid Innovation. Prescription Drug Price Reform.
4th Quarter (Oct 1 - Dec 31) 2020 · AKIN GUMP STRAUSS HAUER & FELD · $50K · Active
- Filing ID
- 763abf75-9a52-4893-a21e-9f272dc5a6e6
- Filing type
- 4th Quarter - Report (Q4)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Jan 20, 2021
Health Issues
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, H.R. 133 Coronavirus Response and Relief Act, health disparities, and COVID-19 vaccine distribution.
Pharmacy
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800, Heroes Act, H.R. 133 Covid Response and Relief Act; and COVID-19 vaccine distribution.
3rd Quarter (July 1 - Sep 30) 2020 · AKIN GUMP STRAUSS HAUER & FELD · $50K · Active
- Filing ID
- 3eb78a07-2bd8-4de7-ae65-e432c45dc6cd
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- AKIN GUMP STRAUSS HAUER & FELD
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 20, 2020
Health Issues
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution.
Medicare/Medicaid
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800 Heroes Act, and COVID-19 vaccine distribution.
Pharmacy
Issues related to Medicare Part D payments; matters related to response to COVID-19 outbreak/H.R. 748 - CARES Act; H.R. 6800, Heroes Act, and COVID-19 vaccine distribution.
3rd Quarter (July 1 - Sep 30) 2020 · TODD STRATEGY GROUP · $50K · Active
- Filing ID
- 5e2a4111-a460-444b-8a18-f6e9a0cec092
- Filing type
- 3rd Quarter - Report (Q3)
- Registrant
- TODD STRATEGY GROUP
- Client
- MCKESSON CORPORATION
- Amount classification
- Outside-firm income
- Filed
- Oct 19, 2020
Medicare/Medicaid
General Medicare/Medicaid Issues.
Source: U.S. House and Senate Lobbying Disclosure Act database / LDA.gov. Data last retrieved Aug 27, 2026. The Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Document library
Important Documents
Selected filings, reports, contracts, court records, and other documents useful for understanding this organization.
SEC Exhibit 21Company filing
McKesson Exhibit 21 — Subsidiaries
McKesson · May 8, 2026
Company-filed list of significant subsidiaries. The filing may omit subsidiaries that are not considered significant under SEC rules.
Documentation
Sources
- Original source ↗
Federal data refreshed September 19, 2026.
For researchers
Cite this page
The Paper Trail Project. “McKesson.” Accessed September 23, 2026. https://www.papertrailproject.org/profiles/mckesson
Record last updated 2026-09-19. Sources: Linked public records. Verify consequential claims against the linked original records.